Achieve economies of scale with exacting quality and timely delivery
Costs in every aspect of drug/biologic development and delivery have continued to escalate at the same time that policy authorities have advanced value and effectiveness as a means to determine access and reimbursement levels. To address this, HERON provides offshore science and research capabilities in evidence development, providing deliverables that meet exacting quality assurance standards and can be developed in quantity and on demanding time schedules. Offered at cost-effective pricing for clients seeking to innovate through gains in operational efficiency, and Active Evidence Review™ Service clients, HERON’s offshore capacity takes the ‘pain’ out of evidence review generation for those companies experiencing budget cuts and efficiency measures.
To better understand how HERON's offshore/onshore development process can meet your requirements, please contact us, and a HERON representative will swiftly be in touch.